Paclitaxel and TAK-228
X31005
Phase 2 other active
Quick answer
Paclitaxel and TAK-228 for Metastatic Urothelial Cancer is a Phase 2 program (other) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Metastatic Urothelial Cancer
- Phase
- Phase 2
- Modality
- other
- Status
- active